Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- OPINION
May 8, 2006
- GCP Auditing Business
May 8, 2006
- HUMAN RESOURCES NEWS IN BRIEF
May 8, 2006
- Epidemiological Data Essential for Strategic Marketing: Mr Robinson of Mattson Jack
May 8, 2006
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
May 8, 2006
- BUSINESS NEWS IN BRIEF
May 8, 2006
- JPMA
May 8, 2006
- Approval of 32 New Drug Products Notified
May 8, 2006
- Chuikyo Recommends
May 8, 2006
- Gabapentin, Mozavaptan
May 8, 2006
- JPMA Asks Korosho to Lighten Industry's
May 8, 2006
- MEDICAL DEVICE NEWS IN BRIEF
May 8, 2006
- STATISTICS
May 8, 2006
- SEMINAR
May 8, 2006
- REGULATORY NEWS IN BRIEF
May 8, 2006
- RDKK Supports Nursery for Female Doctors with Children
May 8, 2006
- JT Licenses New Drug Candidate to GSK
May 8, 2006
- SELF-MEDICATION NEWS IN BRIEF
May 8, 2006
- DIA WORKSHOP
May 8, 2006
- SURVEY 2 articles
May 8, 2006
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…